🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06713291
Recruiting Not applicable

Clinical Study of a Novel Sliding Compression Locking Plate in the Treatment of Fresh Femoral Neck Fractures

NCT06713291 · tracked via the Priya Life Science China tracker
Sponsor
Chinese PLA General Hospital
Phase
Not applicable
Started
2024-12-10
Last updated
2026-04-02

Condition(s) studied

Fracture of Femoral Neck

Investigational drug(s) / intervention(s)

Sliding compression locking plateThree cannulated compression screws

Sliding compression locking plate: The patients with femoral neck fracture were treated with three cannulated compression screws or sliding compression locking plate.

Three cannulated compression screws: The patients with femoral neck fracture were treated with three cannulated compression screws.

Study summary

To verify the safety and efficacy of sliding compression locking plates in the treatment of fresh femoral neck fractures

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Age \>=18 years old, gender is not limited; 2. Patients diagnosed with femoral neck fracture; 3. Patients with indications for internal fixation of femoral neck fracture and able to tolerate surgery; 4. The subject or his legal representative is informed of the nature of the study and agrees to participate in the study. Exclusion Criteria: 1. Participants who had participated in clinical studies of other drugs, biologics or medical devices before enrollment and did not reach the primary study endpoint time limit; 2. The patient is known to have a history of allergy to one or more implanted materials; 3. Patients determined by researchers to be physically weak or unable to tolerate surgery due to other systemic diseases; 4. Active infection of the hip joint or other parts of the body is determined by the investigator; 5. Diagnosed as metabolic bone disease, radiation bone disease, etc.; 6. Severe hip contracture deformity or severe muscle loss fused to the functional position for a long time without pain; 7. have inflammatory arthritis, such as rheumatoid arthritis, systemic lupus erythematosus arthritis, ankylosing spondylitis, etc.; 8. The patient is mentally incapable or unable to understand the requirements of participating in the study, and it is difficult to cooperate; 9. Other conditions deemed unsuitable for inclusion by the investigator.

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
the First Centre of PLA General Hospital Beijing Beijing Municipality Recruiting
Chinese PLA General Hosptial Beijing China Not Yet Recruiting
the First Medical Center of PLA General Hospital Beijing China Recruiting

More Chinese PLA General Hospital trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06713291 on ClinicalTrials.gov ↗ ← All trials in China